CME Group CIO granted 2,864 restricted shares

CME Group’s CIO was granted 2,864 restricted shares and surrendered 1,413 shares back to the company for tax withholding tied to prior awards.

Rhea-AI Filing Summary

CME GROUP INC. (CME) reported that Chief Information Officer Sunil Cutinho received a grant of 2,864 shares of Class A common stock on September 15, 2026 as restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. On September 15 and 16, he surrendered a total of 1,413 shares to CME Group to satisfy tax withholding obligations related to the vesting of previously granted restricted stock.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Cutinho Sunil

Role Chief Information Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock Class A F2	359	$272.46	$98K
Grant/Award	Common Stock Class A F1	2,864	$275.09	$788K
Tax Withholding	Common Stock Class A F2	373	$275.09	$103K
Tax Withholding	Common Stock Class A F2	361	$275.09	$99K
Tax Withholding	Common Stock Class A F2	320	$275.09	$88K

Holdings After Transaction: Common Stock Class A — 25,037 shares (Direct)

Footnotes (2)

1. F1. Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
2. F2. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Key Figures

Restricted stock granted: 2,864 shares Grant price per share: $275.09 per share Shares surrendered for tax withholding: 1,413 shares +3 more

6 metrics

Restricted stock granted 2,864 shares Grant of CME Class A common stock on September 15, 2026

Grant price per share $275.09 per share Restricted stock grant to CIO on September 15, 2026

Shares surrendered for tax withholding 1,413 shares Code F dispositions on September 15–16, 2026

Tax-withholding price (Sept 15, 2026) $275.09 per share Shares surrendered to satisfy tax withholding

Tax-withholding price (Sept 16, 2026) $272.46 per share Shares surrendered to satisfy tax withholding

Vesting schedule 4 equal annual installments Restricted stock vesting terms subject to continued service

Key Terms

restricted stock, CME Group Omnibus Stock Plan, tax withholding obligations, Chief Information Officer

4 terms

restricted stock financial

"Represents a grant of restricted stock under the CME Group Omnibus Stock Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

CME Group Omnibus Stock Plan financial

"Represents a grant of restricted stock under the CME Group Omnibus Stock Plan"

tax withholding obligations financial

"satisfy tax withholding obligations in connection with the vesting of restricted stock"

Chief Information Officer other

"Cutinho Sunil is reported as Chief Information Officer"

A chief information officer (CIO) is a senior executive responsible for managing a company's technology and information systems. They ensure that technology supports the organization’s goals, much like a conductor coordinating an orchestra to create harmonious music. Investors care about CIOs because their decisions and strategies can influence a company's efficiency, security, and ability to adapt to new digital opportunities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CME (CME) disclose for Sunil Cutinho?

CME disclosed that CIO Sunil Cutinho received a grant of 2,864 restricted shares of Class A common stock on September 15, 2026 and surrendered 1,413 shares on September 15–16, 2026 to CME to satisfy tax withholding on previously vested restricted stock.

What kind of equity award did the CME (CME) CIO receive?

Sunil Cutinho received a grant of 2,864 shares of restricted stock under the CME Group Omnibus Stock Plan. The award vests in four equal annual installments, and vesting is subject to continued service.

At what prices were the CME (CME) insider transactions reported?

The restricted stock grant to Sunil Cutinho was reported at $275.09 per share. The shares surrendered for tax withholding were reported at $275.09 per share on September 15, 2026 and $272.46 per share on September 16, 2026.

How many CME (CME) shares were surrendered for tax withholding?

Sunil Cutinho surrendered a total of 1,413 shares of CME Class A common stock to CME Group to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock.

Were the CME (CME) CIO’s transactions made under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not checked, and the footnotes describe tax withholding and restricted stock terms; no Rule 10b5-1 trading plan is reported for these transactions.

What plan governs the restricted stock granted to the CME (CME) CIO?

The restricted stock granted to Sunil Cutinho was issued under the CME Group Omnibus Stock Plan, with the award vesting in four equal annual installments, subject to his continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:19 PM Accepted by SEC EDGAR 09/17/2026 - 04:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cutinho Sunil

(Last) (First) (Middle)

20 S. WACKER DRIVE

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock Class A	09/15/2026		A(1)		2,864	A	$275.09	26,450	D
Common Stock Class A	09/15/2026		F(2)		373	D	$275.09	26,077	D
Common Stock Class A	09/15/2026		F(2)		361	D	$275.09	25,716	D
Common Stock Class A	09/15/2026		F(2)		320	D	$275.09	25,396	D
Common Stock Class A	09/16/2026		F(2)		359	D	$272.46	25,037	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.

2. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Remarks:

	/s/ Elizabeth Hensen, as Attorney-in-Fact for Sunil Cutinho	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)